glp-1 obesity drug news october 2025 today How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 CVS obesity drug deal puts
Description
It slows stomach emptying which leads to a slower flow of sugar from the bloodstream to your stomach, ultimately reducing the risk of a blood sugar spike
[DOI] [PubMed] [Google Scholar] 12.Elrick H., Stimmler L., Hlad C.J., Arai Y
They also stimulate GLP-1 secretion
but can be obtained by a physician for patients with refractory gastroparesis though the Investigational New Drug (IND) application program at the FDA
